Clean Design: Reducing Patient Infections Starts with Design for Cleanability

Although the Food and Drug Administration (FDA) has reported progress on reducing overall infection rates with enhanced safety measures and better disinfection methods, the risks associated with reusable medical devices are an ongoing challenge, with drug-resistant microbes and other organisms continuing to survive the cleaning process at an unacceptable rate.1